4//SEC Filing
MANTELLE JUAN A 4
Accession 0001209191-05-044361
CIK 0000815838other
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 5:59 PM ET
Size
14.7 KB
Accession
0001209191-05-044361
Insider Transaction Report
Form 4
MANTELLE JUAN A
VP and Chief Technical Officer
Transactions
- Exercise/Conversion
Common Stock ($.0001 Par Value)
2005-08-24$4.19/sh+1,500$6,285→ 23,346 total - Sale
Common Stock ($.0001 Par Value)
2005-08-24$15.99/sh−1,250$19,988→ 21,846 total - Exercise/Conversion
Stock Option (Right to Buy)
2005-08-24−1,250→ 0 totalExercise: $5.56From: 2005-08-24Exp: 2006-06-21→ Common Stock ($.0001 Par Value) (1,250 underlying) - Sale
Common Stock ($.0001 Par Value)
2005-08-24$15.99/sh−1,500$23,985→ 21,846 total - Exercise/Conversion
Common Stock ($.0001 Par Value)
2005-08-24$5.56/sh+1,250$6,950→ 23,096 total - Exercise/Conversion
Stock Option (Right to Buy)
2005-08-24−1,500→ 0 totalExercise: $4.19From: 2005-08-24Exp: 2005-12-13→ Common Stock ($.0001 Par Value) (1,500 underlying)
Footnotes (2)
- [F1]10% exercisable after 12/14/1999; 20% exercisable after 12/14/2000; 20% exercisable after 12/14/2001; 25% exercisable after 12/14/2002; and 25% exercisable after 12/14/2003. The reporting person has transferred 10,000 of such options to his ex-wife pursuant to a domestic relations order.
- [F2]10% exercisable after 6/22/2000; 20% exercisable after 6/22/2001; 20% exercisable after 6/22/2002; 25% exercisable after 6/22/2003; and 25% exercisable after 6/22/2004. The reporting person has transferred 12,500 of such options to his ex-wife pursuant to a domestic relations order.
Documents
Issuer
NOVEN PHARMACEUTICALS INC
CIK 0000815838
Entity typeother
Related Parties
1- filerCIK 0001224098
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 5:59 PM ET
- Size
- 14.7 KB